{
    "2020-09-17": [
        [
            {
                "time": "",
                "original_text": "甘李药业：自主研发赖脯胰岛素（25R）获北京市新技术新产品认定",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "自主研发",
                        "赖脯胰岛素",
                        "北京市",
                        "新技术",
                        "新产品"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "甘李药业(603087.SH)：甘精胰岛素注射液获哈萨克斯坦药品注册批件",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "甘精胰岛素",
                        "注射液",
                        "哈萨克斯坦",
                        "药品注册",
                        "批件"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "国际业务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}